You are here

  • Home
  • Archive
  • Volume 78, Issue 4
  • Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting

Article metrics

Article menu
Download PDFPDF
Systemic sclerosis
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting

 

Online download statistics by month:

Online download statistics by month: February 2019 to March 2024

AbstractFullPdf
Feb 2019166910451
Mar 2019120514887
Apr 20192625133
May 20192154522
Jun 20191274722
Jul 20191212614
Aug 20191231710
Sep 2019110178
Oct 20191164213
Nov 201977236
Dec 2019901514
Jan 2020100224
Feb 20201361811
Mar 20201622212
Apr 20201321810
May 20201451811
Jun 202014295
Jul 2020156105
Aug 20208471
Sep 2020152245
Oct 2020122139
Nov 2020134111
Dec 20201132512
Jan 202192165
Feb 20213022513
Mar 20211372010
Apr 20212192213
May 20215996
Jun 202113112
Jul 202115138
Aug 2021323114
Sep 202129137
Oct 202110031
Nov 2021109109
Dec 202113085
Jan 202290114
Feb 2022107259
Mar 2022157166
Apr 202288102
May 202212671
Jun 2022120269
Jul 202211291
Aug 202215773
Sep 20228750
Oct 20227452
Nov 20224891
Dec 20226633
Jan 20234241
Feb 202315253
Mar 202391174
Apr 20236993
May 202354105
Jun 20235753
Jul 202310782
Aug 202311063
Sep 20234151
Oct 20236010
Nov 202325350
Dec 202326061
Jan 202411889
Feb 20247653
Mar 20246423
Total97161142541